- Home
- ONCO vs SPHL Comparison
ONCO vs SPHL Comparison
Compare ONCO & SPHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ONCO
- SPHL
- Stock Information
- Founded
- ONCO 2018
- SPHL 2002
- Country
- ONCO United States
- SPHL Singapore
- Employees
- ONCO N/A
- SPHL N/A
- Industry
- ONCO Biotechnology: Pharmaceutical Preparations
- SPHL Homebuilding
- Sector
- ONCO Health Care
- SPHL Consumer Discretionary
- Exchange
- ONCO Nasdaq
- SPHL Nasdaq
- Market Cap
- ONCO 4.7M
- SPHL 4.9M
- IPO Year
- ONCO 2022
- SPHL 2024
- Fundamental
- Price
- ONCO $3.15
- SPHL $0.44
- Analyst Decision
- ONCO
- SPHL
- Analyst Count
- ONCO 0
- SPHL 0
- Target Price
- ONCO N/A
- SPHL N/A
- AVG Volume (30 Days)
- ONCO 70.5K
- SPHL 2.3M
- Earning Date
- ONCO 12-09-2025
- SPHL 12-29-2025
- Dividend Yield
- ONCO N/A
- SPHL N/A
- EPS Growth
- ONCO N/A
- SPHL N/A
- EPS
- ONCO N/A
- SPHL N/A
- Revenue
- ONCO $1,326,959.00
- SPHL $5,956,226.00
- Revenue This Year
- ONCO N/A
- SPHL N/A
- Revenue Next Year
- ONCO N/A
- SPHL N/A
- P/E Ratio
- ONCO N/A
- SPHL N/A
- Revenue Growth
- ONCO N/A
- SPHL N/A
- 52 Week Low
- ONCO $2.45
- SPHL $0.35
- 52 Week High
- ONCO $251.60
- SPHL $7.80
- Technical
- Relative Strength Index (RSI)
- ONCO 43.15
- SPHL 37.60
- Support Level
- ONCO $3.48
- SPHL $0.53
- Resistance Level
- ONCO $3.99
- SPHL $0.70
- Average True Range (ATR)
- ONCO 0.22
- SPHL 0.09
- MACD
- ONCO -0.04
- SPHL -0.02
- Stochastic Oscillator
- ONCO 21.50
- SPHL 11.33
About ONCO Onconetix Inc.
Onconetix Inc is a commercial-stage biotechnology company focused on the research, development, and commercialization of solutions for men's health and oncology. It has a product named Entadfi an FDA-approved once-daily oral therapeutic for the treatment of benign prostatic hyperplasia, a disorder of the prostate, along with building additional assets in therapeutics, diagnostics, and clinician services for oncology.
About SPHL Springview Holdings Ltd Class A Ordinary Shares
Springview Holdings Ltd is a company that conducts its operations through its indirect wholly-owned subsidiary which designs and constructs residential and commercial buildings in Singapore. It also provides four main types of works which includes new construction, reconstruction, Additions and Alterations (A&A), and other general contracting services such as renovation and design consultation. The company operates and manages its business as a single segment - in the development of construction projects. It derives maximum revenue from its Residential Customers.